Showing results (81-90 of 96) with videos related to
Sort By:
Pageof 10
Journal of Paediatrics and Child Health|July 14, 2020
Predictors of length of hospital stay among preterm infants admitted to neonatal intensive care unit: Data from a multicentre collaborative network from India (INNC: Indian National Neonatal Collaborative)Srinivas Murki, Venkateshwarlu Vardhelli, Saikiran Deshabhotla, et al.Plos One|September 23, 2016
Effectiveness of Onsite Nurse Mentoring in Improving Quality of Institutional Births in the Primary Health Centres of High Priority Districts of Karnataka, South India: A Cluster Randomized TrialKrishnamurthy Jayanna, Janet Bradley, Prem Mony, et al.Trials|November 30, 2021
Comparison of efficacy of a 7-day versus a 14-day course of intravenous antibiotics in the treatment of uncomplicated neonatal bacterial sepsis: study protocol of a randomized controlled non-inferiority trialSourabh Dutta, Sushma Nangia, Mamta Jajoo, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 9, 2019
Updated Analysis of KEYNOTE-024: Pembrolizumab Versus Platinum-Based Chemotherapy for Advanced Non-Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score of 50% or GreaterMartin Reck, Delvys Rodríguez-Abreu, Andrew G Robinson, et al.Eclinicalmedicine|May 30, 2023
Effect on neonatal sepsis following immediate kangaroo mother care in a newborn intensive care unit: a post-hoc analysis of a multicentre, open-label, randomised controlled trialSugandha Arya, Suhail Chhabra, Richa Singhal, et al.Bioorganic & Medicinal Chemistry|January 1, 2017
Studies of TAK1-centered polypharmacology with novel covalent TAK1 inhibitorsLi Tan, Deepak Gurbani, Ellen L Weisberg, et al.The Lancet. Oncology|November 14, 2017
Health-related quality-of-life results for pembrolizumab versus chemotherapy in advanced, PD-L1-positive NSCLC (KEYNOTE-024): a multicentre, international, randomised, open-label phase 3 trialJulie R Brahmer, Delvys Rodríguez-Abreu, Andrew G Robinson, et al.The New England Journal of Medicine|October 11, 2016
Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung CancerMartin Reck, Delvys Rodríguez-Abreu, Andrew G Robinson, et al.Bioorganic & Medicinal Chemistry|December 25, 2016
Structure-guided development of covalent TAK1 inhibitorsLi Tan, Deepak Gurbani, Ellen L Weisberg, et al.Global Pediatrics|April 17, 2023
Immediate skin-to-skin contact for low birth weight infants is safe in terms of cardiorespiratory stability in limited-resource settingsAgnes Linnér, Björn Westrup, Siren Rettedal, et al.Pageof 10